Based on the enrichment results of KEGG, we determined that the effects of TSX against AD may be due to pathways like PI3K-Akt signaling pathway, MAPK signaling pathway, Th17 cell differentiation, and TLR signaling pathway. Here, AKT1 is linked to Alzheimer disease.